These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21192963)

  • 1. Concentration-dependent gene expression responses to flusilazole in embryonic stem cell differentiation cultures.
    van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
    Toxicol Appl Pharmacol; 2011 Mar; 251(2):110-8. PubMed ID: 21192963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.
    van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
    Toxicol Sci; 2011 Jan; 119(1):126-34. PubMed ID: 20935163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes.
    van Dartel DA; Pennings JL; de la Fonteyne LJ; van Herwijnen MH; van Delft JH; van Schooten FJ; Piersma AH
    Toxicol Sci; 2010 Jul; 116(1):130-9. PubMed ID: 20421339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
    van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells.
    van Dartel DA; Pennings JL; van Schooten FJ; Piersma AH
    Toxicol Appl Pharmacol; 2010 Mar; 243(3):420-8. PubMed ID: 20036270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
    van Dartel DA; Piersma AH
    Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn).
    Theunissen PT; Robinson JF; Pennings JL; de Jong E; Claessen SM; Kleinjans JC; Piersma AH
    Toxicol Sci; 2012 Feb; 125(2):430-8. PubMed ID: 22045034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene set assembly for quantitative prediction of developmental toxicity in the embryonic stem cell test.
    Pennings JL; van Dartel DA; Robinson JF; Pronk TE; Piersma AH
    Toxicology; 2011 Jun; 284(1-3):63-71. PubMed ID: 21473898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity.
    Osman AM; van Dartel DA; Zwart E; Blokland M; Pennings JL; Piersma AH
    Reprod Toxicol; 2010 Sep; 30(2):322-32. PubMed ID: 20553848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
    van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-response evaluation by transcriptomics of methylmercury effects on neural differentiation of murine embryonic stem cells.
    Theunissen PT; Pennings JL; Robinson JF; Claessen SM; Kleinjans JC; Piersma AH
    Toxicol Sci; 2011 Aug; 122(2):437-47. PubMed ID: 21613230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
    Festag M; Viertel B; Steinberg P; Sehner C
    Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles.
    de Jong E; Barenys M; Hermsen SA; Verhoef A; Ossendorp BC; Bessems JG; Piersma AH
    Toxicol Appl Pharmacol; 2011 Jun; 253(2):103-11. PubMed ID: 21443896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-response analysis of differential gene expression in the zebrafish embryotoxicity test following flusilazole exposure.
    Hermsen SA; Pronk TE; van den Brandhof EJ; van der Ven LT; Piersma AH
    Toxicol Sci; 2012 May; 127(1):303-12. PubMed ID: 22382673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A statistical approach towards the derivation of predictive gene sets for potency ranking of chemicals in the mouse embryonic stem cell test.
    Schulpen SH; Pennings JL; Tonk EC; Piersma AH
    Toxicol Lett; 2014 Mar; 225(3):342-9. PubMed ID: 24480513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound-specific effects of diverse neurodevelopmental toxicants on global gene expression in the neural embryonic stem cell test (ESTn).
    Theunissen PT; Robinson JF; Pennings JL; van Herwijnen MH; Kleinjans JC; Piersma AH
    Toxicol Appl Pharmacol; 2012 Aug; 262(3):330-40. PubMed ID: 22634333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
    Stummann TC; Hareng L; Bremer S
    Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds.
    de Jong E; Louisse J; Verwei M; Blaauboer BJ; van de Sandt JJ; Woutersen RA; Rietjens IM; Piersma AH
    Toxicol Sci; 2009 Jul; 110(1):117-24. PubMed ID: 19401353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.
    Pal R; Mamidi MK; Das AK; Bhonde R
    J Cell Physiol; 2011 Jun; 226(6):1583-95. PubMed ID: 20945368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in energy metabolism upon embryonic stem cell differentiation support developmental toxicant identification.
    van Dartel DA; Schulpen SH; Theunissen PT; Bunschoten A; Piersma AH; Keijer J
    Toxicology; 2014 Oct; 324():76-87. PubMed ID: 25089837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.